Consumption of legumes improves certain bone markers in ovariectomized rats

Nutrition Research

Volumn 31, Issue 5, 2011, Pages 397-403

  Lee, Sun Hee ^a   Jin, Na ^a   Paik, Doo Jin ^a   Kim, Deog Yoon ^b   Chung, Ill Min ^c   Park, Yongsoon ^a  

^a Hanyang University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

Adzuki bean; Bone metabolism; Cowpea; Mung bean; Ovariectomized; Rat; Soybean

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; DEOXYPYRIDINOLINE; ESTRADIOL; OSTEOCALCIN; PHOSPHORUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE REMODELING; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CONTROLLED STUDY; COWPEA; DIETARY INTAKE; ESTRADIOL BLOOD LEVEL; FEMALE; LEGUME; MORPHOMETRICS; MUNG BEAN; NONHUMAN; ORGAN WEIGHT; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SOYBEAN; SPRAGUE DAWLEY RAT; THERAPY EFFECT; URINARY EXCRETION;

AMINO ACIDS; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; CALCIUM; ESTRADIOL; FABACEAE; FEMALE; OSTEOCALCIN; OSTEOPOROSIS; OVARIECTOMY; PHOSPHORUS; PHYTOTHERAPY; PLANT PREPARATIONS; RATS; RATS, SPRAGUE-DAWLEY; SEEDS;

GLYCINE MAX; RATTUS; VIGNA ANGULARIS; VIGNA RADIATA VAR. RADIATA;

EID: 79957707811     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.04.006     Document Type: Article

References (45)

1. Korea Centers for Disease Control and Prevention The Fourth Korea National Health and Nutrition Examination Survey (KNHANES 4), Nutrition survey 2009, Ministry for Health, Welfare and Family Affairs.
2. Peel N. Bone remodeling and disorders of bone metabolism. Surgery 2009, 27:70-74.
3. Bart L., Clarke M.D. Physiology of bone loss. Radiol Clin North Am 2010, 48(3):483-495.
4. Stevenson J.C. Justification for the use of HRT in the long-term prevention of osteoporosis. Maturitas 2005, 51(2):113-126.
5. Prelevic G.M., Kocjan T., Markou A. Hormone replacement therapy in postmenopausal women. Minerva Endocrinol 2005, 30(1):27-36.
6. Davison S., Davis S.R. Hormone replacement therapy: current controversies. Clin Endocrinol (Oxf) 2003, 58(3):249-261.
7. Wiseman R.A. Breast cancer: critical data analysis concludes that estrogens are not the cause, however lifestyle changes can alter risk rapidly. J Clin Epidemiol 2004, 57(8):766-772.
8. Messina M.J. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr 1999, 70(S):439-450.
9. Sirton C.R. Risks and benefits of soy phytoestrogens in cardiovascular disease, cancer, climacteric symptoms and osteoporosis. Drug Safety 2001, 24:665-682.
10. Kronenberg F., Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review randomized, controlled trials. Ann Intern Med 2002, 137:805-813.
11. Clarkson T.B. Soy, soy phytoestrogens and cardiovascular disease. J Nutr 2002, 132(3):566S-569S.
12. Turner J.V., Agatonovic-Kustrin S., Glass B.D. Molecular aspects of phytoestrogen selective binding at estrogen receptors. J Pharm Sci 2007, 96:1879-1885.
13. Picherit C., Bennetau-Pelissero C., Chanteranne B., Lebecque P., Davicco M.J., Barlet J.P., et al. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 2001, 131(3):723-728.
14. Rozman K.K., Bhatia J., Calafat A.M., Chambers C., Culty M., Etzel R.A., et al. NTR-CERHR expert panel report on the reproductive and developmental toxicity of genistein. Birth Defects Research 2006, 77:485-638.
15. Arjmandi B.H., Alekel L., Hollis B.W., Amin D., Stacewicz-Sapuntzakis M., Guo P., et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996, 126(1):161-167.
16. Alekel D.L., Germain A.S., Peterson C.T., Hanson K.B., Stewart J.W., Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000, 72(3):844-852.
17. Valverde P., Zhang J., Fix A., Zhu J., Ma W., Tu Q., et al. Overexpression bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice. J Bone Miner Res 2008, 23(11):1775-1788.
18. Zhou X., Zhang P., Zhang C., Zhu Z. Promotion of bone formation by naringin in a titanium particle-induced diabetic murine calvarial osteolysis model. Journal of Orthopaedic Research 2009, 29(4):451-456.
19. Jo H., Choi M. Effects of isoflavone supplementation on the bone mineral density of growing female rats. Nutr Res Pract 2008, 2(2):68-73.
20. Waarsing J.H., Day J.S., Weinans H. An improved segmentation method for in vivo micro CT imaging. J Bone Miner Res 2004, 19(10):1640-1650.
21. Kinney J.H., Haupt D.L., Balooch M., Ladd A.J.C., Ryaby J.T., Lane N.E. Three dimensional morphometry of the L6 vertebra in the ovariectomized rat model of osteoporosis: biomechanical implications. J Bone Miner Res 2000, 15:1981-1991.
22. Devareddy L., Khalil D.A., Smith B.J., Lucas E.A., Soung D.Y., Marlow D.D., et al. Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis. Bone 2006, 38:686-693.
23. Draper C.R., Edel M.J., Dick I.M., Randall A.G., Martin G.B., Prince R.L. Phytoestrogen reduce bone loss and bone resorption in oophorectomized rats. J Nutr 1997, 127:1795-1799.
24. Fanti P., Monier-Faugere M.C., Geng Z., Schmidt J., Morris P.E., Cohen D., et al. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporosis Int 1998, 8:274-281.
25. Byun J.S., Lee S.S. Effect of soybeans and sword beans on bone metabolism in a rat model of osteoporosis. Ann Nutr Metab 2010, 56:106-112.
26. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79:727-747.
27. Lin P.Y., Lai H.M. Bioactive compounds in legumes and their germinated products. J Agric Food Chem 2006, 54(11):3807-3814.
28. Lee S., Lee M., Yoon S., Kwon D. Estimated isoflavone intake from soy products in Korean middle-aged women. J Korean Soc Food Sci Nutr 2000, 29(5):948-956.
29. Pichert C., Chanteranne B., Bennetau-Pelissero C., Davicco M., Lebecque P., Barlet J., et al. Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomized rat. Br J Nutr 2001, 85:307-316.
30. Jeon B., Ahn J., Kwak H. Effect of isoflavone-enriched milk on bone mass in ovariectomized rats. J Med Food 2009, 12(6):1260-1267.
31. Bouxsein M.L. Mechanisms of osteoporosis therapy: a bone strength perspective. Clin Cornerstone 2003, 2:13-21.
32. Borah B., Dufresne T.E., Chmielewski P.A., Gross G.J., Prenger M.C., Phipps R.J. Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography. J Bone Miner Res 2002, 17(7):1139-1147.
33. Müller R., Hannan M., Smith S.Y., Bauss F. Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey. J Bone Miner Res 2004, 19(11):1787-1796.
34. Lane N.E., Kumer J.L., Majumdar S., Khan M., Lotz J., Stevens R.E., et al. The effects of synthetic conjugated estrogens, a (Cenestin) on trabecular bone structure and strength in the ovariectomized rat model. Osteoporos Int 2002, 13(10):816-823.
35. Park J.H., Omi N., Nosaka T., Kitajima A., Ezawa I. Estrogen deficiency and low-calcium diet increased bone loss and urinary calcium excretion but did not alter arterial stiffness in young female rats. J Bone Miner Metab 2008, 26:218-225.
36. Choi M.J. Effects of taurine supplementation on bone mineral density in ovariectomized rats fed calcium deficient diet. Nutr Res Pract 2009, 3(2):108-113.
37. Hagenfeldt Y., Eriksson H.A. The estrogen receptor in the rat kidney. Ontogeny, properties and effects of gonadectomy on its concentration. J Steroid Biochem 1988, 31(1):49-56.
38. Nordin B.E., Need A.G., Morris H.A., Horowitz M. The nature and significance of the relationship between urinary sodium and urinary calcium in women. J Nutr 1993, 123(9):1615-1622.
39. Riggs B.L., Melton L.J. Involutional osteoporosis. N Engl J Med 1986, 314(26):1676-1686.
40. Choi E.M., Suh K.S., Kim Y.S., Choue R.W., Koo S.J. Soybean ethanol extract increase the function of osteoblastic MC3T3-E1 cells. Phytochemistry 2001, 56:733-739.
41. Lee Y.S., Chen X., Anderson J.J.B. Physiological concentrations of genistein stimulate the proliferation and protect against free radical-induced oxidative damage of MC3T3-E1 osteoblast-like cells. Nutr Res 2001, 21:1287-1298.
42. Chen X.W., Garner S.C., Anderson J.J.B. Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. BBRC 2002, 295:417-422.
43. Devareddy L., Soung D., Khalil D.A., Lucas E.A., Smith B.J., Arquitt A.B. Soy isoflavones may increase bone formation as seen by enhanced osteoblast-specific gene products in ovariectomized rat model of postmenopausal osteoporosis. J Bone Miner Res 2004, S218.
44. Leino A., Järvisalo J., Impivaara O., Kaitsaari M. Ovarian hormone status, life-style factors, and markers of bone metabolism in women aged 50 years. Calcif Tissue Int 1994, 54(4):262-267.
45. Uebelhart D., Gineyts E., Chapuy M.C., Delmas P.D. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 1990, 8(1):87-96.